 | • レポートコード：MRC2-11QY11738 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエボラ治療のグローバル市場について調査・分析したレポートです。種類別（ワクチン（試験中）、薬剤（試験中））市場規模、用途別（病院、外来手術センター、専門クリニック、陸軍キャンプ（ベテラン施設））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エボラ治療の競争状況、市場シェア ・世界のエボラ治療市場：種類別市場規模 2015年-2020年（ワクチン（試験中）、薬剤（試験中）） ・世界のエボラ治療市場：種類別市場規模予測 2021年-2026年（ワクチン（試験中）、薬剤（試験中）） ・世界のエボラ治療市場：用途別市場規模 2015年-2020年（病院、外来手術センター、専門クリニック、陸軍キャンプ（ベテラン施設）） ・世界のエボラ治療市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、専門クリニック、陸軍キャンプ（ベテラン施設）） ・北米のエボラ治療市場分析：米国、カナダ ・ヨーロッパのエボラ治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエボラ治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエボラ治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエボラ治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Arbutus Biopharma、GlaxoSmithKline、Johnson & Johnson Services、Hemispherx Biopharma、BioCryst Pharmaceuticals、NanoViricides、NewLink Genetics、Chimerix、Sarepta Therapeutics、Mapp Biopharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc. Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally. As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.
The global Ebola treatment market growth is driven by the increasing incidence rates of Ebola viral infection and Ebola outbreaks. As per WHO, U.S. & U.K. governments, availability of different treatment procedures to treat Ebola is expected to drive the Ebola viral disease market growth during the forecast period. The Ebola treatment market also includes therapies for those who already have Ebola, and vaccines to prevent the deadly virus. Various drug companies and regulators in the U.S. are taking a two-pronged approach in finding a way to treat the virus. Approval of vaccines are taking a longer time but when vaccines undergo trials, adoption and availability could be a limiting factor for global Ebola treatment market growth.
Market Analysis and Insights: Global Ebola Treatment Market
The global Ebola Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ebola Treatment Scope and Market Size
Ebola Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ebola Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Arbutus Biopharma
GlaxoSmithKline
Johnson & Johnson Services
Hemispherx Biopharma
BioCryst Pharmaceuticals
NanoViricides
NewLink Genetics
Chimerix
Sarepta Therapeutics
Mapp Biopharmaceutical
Market segment by Type, the product can be split into
Vaccine (Under Trials)
Drugs (Under Trials)
Market segment by Application, split into
Hospitals
Ambulatory Surgery Centres
Specialized Clinics
Army Camps (Veteran Facilities)
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ebola Treatment Revenue
1.4 Market by Type
1.4.1 Global Ebola Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Vaccine (Under Trials)
1.4.3 Drugs (Under Trials)
1.5 Market by Application
1.5.1 Global Ebola Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgery Centres
1.5.4 Specialized Clinics
1.5.5 Army Camps (Veteran Facilities)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ebola Treatment Market Perspective (2015-2026)
2.2 Global Ebola Treatment Growth Trends by Regions
2.2.1 Ebola Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ebola Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Ebola Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ebola Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Ebola Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ebola Treatment Players by Market Size
3.1.1 Global Top Ebola Treatment Players by Revenue (2015-2020)
3.1.2 Global Ebola Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Ebola Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ebola Treatment Market Concentration Ratio
3.2.1 Global Ebola Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ebola Treatment Revenue in 2019
3.3 Ebola Treatment Key Players Head office and Area Served
3.4 Key Players Ebola Treatment Product Solution and Service
3.5 Date of Enter into Ebola Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ebola Treatment Historic Market Size by Type (2015-2020)
4.2 Global Ebola Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ebola Treatment Market Size by Application (2015-2020)
5.2 Global Ebola Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ebola Treatment Market Size (2015-2020)
6.2 Ebola Treatment Key Players in North America (2019-2020)
6.3 North America Ebola Treatment Market Size by Type (2015-2020)
6.4 North America Ebola Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ebola Treatment Market Size (2015-2020)
7.2 Ebola Treatment Key Players in Europe (2019-2020)
7.3 Europe Ebola Treatment Market Size by Type (2015-2020)
7.4 Europe Ebola Treatment Market Size by Application (2015-2020)
8 China
8.1 China Ebola Treatment Market Size (2015-2020)
8.2 Ebola Treatment Key Players in China (2019-2020)
8.3 China Ebola Treatment Market Size by Type (2015-2020)
8.4 China Ebola Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ebola Treatment Market Size (2015-2020)
9.2 Ebola Treatment Key Players in Japan (2019-2020)
9.3 Japan Ebola Treatment Market Size by Type (2015-2020)
9.4 Japan Ebola Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ebola Treatment Market Size (2015-2020)
10.2 Ebola Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ebola Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Ebola Treatment Market Size by Application (2015-2020)
11 India
11.1 India Ebola Treatment Market Size (2015-2020)
11.2 Ebola Treatment Key Players in India (2019-2020)
11.3 India Ebola Treatment Market Size by Type (2015-2020)
11.4 India Ebola Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ebola Treatment Market Size (2015-2020)
12.2 Ebola Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Ebola Treatment Market Size by Type (2015-2020)
12.4 Central & South America Ebola Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Arbutus Biopharma
13.1.1 Arbutus Biopharma Company Details
13.1.2 Arbutus Biopharma Business Overview
13.1.3 Arbutus Biopharma Ebola Treatment Introduction
13.1.4 Arbutus Biopharma Revenue in Ebola Treatment Business (2015-2020))
13.1.5 Arbutus Biopharma Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Ebola Treatment Introduction
13.2.4 GlaxoSmithKline Revenue in Ebola Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Johnson & Johnson Services
13.3.1 Johnson & Johnson Services Company Details
13.3.2 Johnson & Johnson Services Business Overview
13.3.3 Johnson & Johnson Services Ebola Treatment Introduction
13.3.4 Johnson & Johnson Services Revenue in Ebola Treatment Business (2015-2020)
13.3.5 Johnson & Johnson Services Recent Development
13.4 Hemispherx Biopharma
13.4.1 Hemispherx Biopharma Company Details
13.4.2 Hemispherx Biopharma Business Overview
13.4.3 Hemispherx Biopharma Ebola Treatment Introduction
13.4.4 Hemispherx Biopharma Revenue in Ebola Treatment Business (2015-2020)
13.4.5 Hemispherx Biopharma Recent Development
13.5 BioCryst Pharmaceuticals
13.5.1 BioCryst Pharmaceuticals Company Details
13.5.2 BioCryst Pharmaceuticals Business Overview
13.5.3 BioCryst Pharmaceuticals Ebola Treatment Introduction
13.5.4 BioCryst Pharmaceuticals Revenue in Ebola Treatment Business (2015-2020)
13.5.5 BioCryst Pharmaceuticals Recent Development
13.6 NanoViricides
13.6.1 NanoViricides Company Details
13.6.2 NanoViricides Business Overview
13.6.3 NanoViricides Ebola Treatment Introduction
13.6.4 NanoViricides Revenue in Ebola Treatment Business (2015-2020)
13.6.5 NanoViricides Recent Development
13.7 NewLink Genetics
13.7.1 NewLink Genetics Company Details
13.7.2 NewLink Genetics Business Overview
13.7.3 NewLink Genetics Ebola Treatment Introduction
13.7.4 NewLink Genetics Revenue in Ebola Treatment Business (2015-2020)
13.7.5 NewLink Genetics Recent Development
13.8 Chimerix
13.8.1 Chimerix Company Details
13.8.2 Chimerix Business Overview
13.8.3 Chimerix Ebola Treatment Introduction
13.8.4 Chimerix Revenue in Ebola Treatment Business (2015-2020)
13.8.5 Chimerix Recent Development
13.9 Sarepta Therapeutics
13.9.1 Sarepta Therapeutics Company Details
13.9.2 Sarepta Therapeutics Business Overview
13.9.3 Sarepta Therapeutics Ebola Treatment Introduction
13.9.4 Sarepta Therapeutics Revenue in Ebola Treatment Business (2015-2020)
13.9.5 Sarepta Therapeutics Recent Development
13.10 Mapp Biopharmaceutical
13.10.1 Mapp Biopharmaceutical Company Details
13.10.2 Mapp Biopharmaceutical Business Overview
13.10.3 Mapp Biopharmaceutical Ebola Treatment Introduction
13.10.4 Mapp Biopharmaceutical Revenue in Ebola Treatment Business (2015-2020)
13.10.5 Mapp Biopharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Ebola Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Ebola Treatment Revenue
Table 3. Ranking of Global Top Ebola Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ebola Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Vaccine (Under Trials)
Table 6. Key Players of Drugs (Under Trials)
Table 7. Global Ebola Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Ebola Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Ebola Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Ebola Treatment Market Share by Regions (2015-2020)
Table 11. Global Ebola Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Ebola Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Ebola Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Ebola Treatment Players
Table 18. Global Ebola Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Ebola Treatment Market Share by Players (2015-2020)
Table 20. Global Top Ebola Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ebola Treatment as of 2019)
Table 21. Global Ebola Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ebola Treatment Product Solution and Service
Table 24. Date of Enter into Ebola Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Ebola Treatment Market Size Share by Type (2015-2020)
Table 28. Global Ebola Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Ebola Treatment Market Size Share by Application (2015-2020)
Table 30. Global Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Ebola Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Ebola Treatment Market Share (2019-2020)
Table 34. North America Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Ebola Treatment Market Share by Type (2015-2020)
Table 36. North America Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Ebola Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Ebola Treatment Market Share (2019-2020)
Table 40. Europe Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Ebola Treatment Market Share by Type (2015-2020)
Table 42. Europe Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Ebola Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Ebola Treatment Market Share (2019-2020)
Table 46. China Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Ebola Treatment Market Share by Type (2015-2020)
Table 48. China Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Ebola Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Ebola Treatment Market Share (2019-2020)
Table 52. Japan Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Ebola Treatment Market Share by Type (2015-2020)
Table 54. Japan Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Ebola Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Ebola Treatment Market Share (2019-2020)
Table 58. Southeast Asia Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Ebola Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Ebola Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Ebola Treatment Market Share (2019-2020)
Table 64. India Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Ebola Treatment Market Share by Type (2015-2020)
Table 66. India Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Ebola Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Ebola Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Ebola Treatment Market Share (2019-2020)
Table 70. Central & South America Ebola Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Ebola Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Ebola Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Ebola Treatment Market Share by Application (2015-2020)
Table 74. Arbutus Biopharma Company Details
Table 75. Arbutus Biopharma Business Overview
Table 76. Arbutus Biopharma Product
Table 77. Arbutus Biopharma Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 78. Arbutus Biopharma Recent Development
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Product
Table 82. GlaxoSmithKline Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Recent Development
Table 84. Johnson & Johnson Services Company Details
Table 85. Johnson & Johnson Services Business Overview
Table 86. Johnson & Johnson Services Product
Table 87. Johnson & Johnson Services Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Services Recent Development
Table 89. Hemispherx Biopharma Company Details
Table 90. Hemispherx Biopharma Business Overview
Table 91. Hemispherx Biopharma Product
Table 92. Hemispherx Biopharma Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 93. Hemispherx Biopharma Recent Development
Table 94. BioCryst Pharmaceuticals Company Details
Table 95. BioCryst Pharmaceuticals Business Overview
Table 96. BioCryst Pharmaceuticals Product
Table 97. BioCryst Pharmaceuticals Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 98. BioCryst Pharmaceuticals Recent Development
Table 99. NanoViricides Company Details
Table 100. NanoViricides Business Overview
Table 101. NanoViricides Product
Table 102. NanoViricides Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 103. NanoViricides Recent Development
Table 104. NewLink Genetics Company Details
Table 105. NewLink Genetics Business Overview
Table 106. NewLink Genetics Product
Table 107. NewLink Genetics Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 108. NewLink Genetics Recent Development
Table 109. Chimerix Business Overview
Table 110. Chimerix Product
Table 111. Chimerix Company Details
Table 112. Chimerix Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 113. Chimerix Recent Development
Table 114. Sarepta Therapeutics Company Details
Table 115. Sarepta Therapeutics Business Overview
Table 116. Sarepta Therapeutics Product
Table 117. Sarepta Therapeutics Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 118. Sarepta Therapeutics Recent Development
Table 119. Mapp Biopharmaceutical Company Details
Table 120. Mapp Biopharmaceutical Business Overview
Table 121. Mapp Biopharmaceutical Product
Table 122. Mapp Biopharmaceutical Revenue in Ebola Treatment Business (2015-2020) (Million US$)
Table 123. Mapp Biopharmaceutical Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ebola Treatment Market Share by Type: 2020 VS 2026
Figure 2. Vaccine (Under Trials) Features
Figure 3. Drugs (Under Trials) Features
Figure 4. Global Ebola Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgery Centres Case Studies
Figure 7. Specialized Clinics Case Studies
Figure 8. Army Camps (Veteran Facilities) Case Studies
Figure 9. Ebola Treatment Report Years Considered
Figure 10. Global Ebola Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Ebola Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Ebola Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Ebola Treatment Market Share by Players in 2019
Figure 15. Global Top Ebola Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ebola Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Ebola Treatment Revenue in 2019
Figure 17. North America Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Ebola Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …- 仮想臨床試験の世界市場（～2026年） Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms. Virtual clinical tr…
- 外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…
- e-臨床試験の世界市場（～2026年） Market Analysis and Insights: Global e-clinical Trials Market The global e-clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global e-clinical Trials Scope and Market Size e-clinical Trials market is segmented b…
- 臨床試験画像の世界市場（～2026年） Market Analysis and Insights: Global Clinical Trials Imaging Market The global Clinical Trials Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Clinical Trials Imaging Scope and Market Size Clinical Trials Imagi…